Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
22
# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
79%
ALSO IN IBB
IBB
260
HOLDINGS
11%
ALSO IN PBE
SECTOR DRIFT (PBE minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 4.9% | 8.7% | 4.9% |
|
AMGEN INC | 4.8% | 7.6% | 4.8% |
|
REGENERON PHARMACEUTICALS | 4.8% | 7.0% | 4.8% |
|
GILEAD SCIENCES INC | 4.6% | 7.8% | 4.6% |
|
BIOGEN IDEC INC | 5.5% | 2.4% | 2.4% |
PBE Overweight Relative to IBB
|
ROYALTY PHARMA PLC CLASS A | 4.7% |
|
EXACT SCIENCES CORP | 3.1% |
|
BIOGEN IDEC INC | 3.1% |
|
IONIS PHARMACEUTICALS, INC. | 3.1% |
|
INCYTE CORP | 3.1% |
|
ILLUMINA INC | 3.0% |
|
SAREPTA THERAPEUTICS INC | 3.0% |
|
VERACYTE INC | 2.9% |
|
PTC THERAPEUTICS INC | 2.9% |
|
CATALYST PHARMACEUTICAL PART | 2.7% |
PBE Underweight Relative to IBB
|
ALNYLAM PHARMACEUTICALS INC | -4.5% |
|
VERTEX PHARMACEUTICALS INC | -3.8% |
|
INSMED INC | -3.2% |
|
GILEAD SCIENCES INC | -3.2% |
|
AMGEN INC | -2.8% |
 |
ARGENX SE ADR | -2.8% |
|
NATERA INC | -2.7% |
|
REGENERON PHARMACEUTICALS | -2.2% |
|
BEIGENE LTD. SPONSORED ADR | -2.1% |
|
REVOLUTION MEDICINES, INC. | -1.7% |